Author:
Lv Hua,Wang Fan,Reddy M. V. Ramana,Zhou Qingyu,Zhang Xiaoping,Reddy E. Premkumar,Gallo James M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference39 articles.
1. Challenges and Opportunities Report (CDER) (2004) Innovation and stagnation: Challenge and opportunity on the critical path to new medicinal products. US Food and Drug Administration
2. Zerhouni E (2003) Medicine. The NIH Roadmap. Science 302:63–72
3. Wang S, Guo P, Wang X, Zhou Q, Gallo JM (2008) Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor models. Mol Cancer Ther 7:407–417
4. Wang S, Zhou Q, Gallo JM (2009) Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinib. Mol Cancer Ther 8:1438–1447
5. He K, Qian M, Wong H, Bai SA, He B, Brogdon B et al (2008) N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations. J Pharm Sci 97:2568–2580
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献